herpes zoster |
Disease ID | 720 |
---|---|
Disease | herpes zoster |
Manually Symptom | (Waiting for update.) |
Text Mined Symptom | UMLS | Name | Sentences' Count(Total Symptoms:27) C0030193 | pain | 27 C0009450 | infection | 12 C0027796 | neuralgia | 7 C0032768 | postherpetic neuralgia | 6 C0021311 | infections | 6 C0003864 | arthritis | 6 C0423716 | neuropathic pain | 5 C0015230 | rash | 5 C0024141 | systemic lupus erythematosus | 5 C0184567 | acute pain | 3 C0027813 | neuritis | 3 C0278140 | severe pain | 3 C0030552 | paresis | 3 C0009377 | colonic pseudo-obstruction | 2 C0033860 | psoriasis | 2 C0029089 | ophthalmoplegia | 2 C0014038 | encephalitis | 2 C0025289 | meningitis | 1 C0008049 | chickenpox | 1 C0341742 | acute urinary retention | 1 C0263358 | erythema annulare centrifugum | 1 C0015469 | facial paralysis | 1 C1834580 | ramsay hunt syndrome | 1 C0037284 | skin lesions | 1 C0037284 | skin lesion | 1 C0015464 | facial palsy | 1 C1839611 | n syndrome | 1 |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
All Snps(Total Genotypes:1) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
rs114864815 | 25297839 | 10866 | HCP5 | umls:C0019360 | GWASCAT | Genetic variation in the HLA region is associated with susceptibility to herpes zoster. | 0.12 | 2014 | NA | NA | NA | NA | NA |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:0) |
---|
(Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
---|
(Waiting for update.) |
Chemical(Total Drugs:2) | |||||||||
---|---|---|---|---|---|---|---|---|---|
CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
C0019360 | famciclovir | C060590 | 104227-87-4 | herpes zoster | MESH:D006562 | therapeutic | 15181487 | ||
C0019360 | methotrexate | D008727 | 1959/5/2 | herpes zoster | MESH:D006562 | marker/mechanism | 8779788 |
FDA approved drug and dosage information(Total Drugs:2) | ||||||||
---|---|---|---|---|---|---|---|---|
DiseaseID | Drug_name | active_ingredients | strength | Dosage Form/Route | Marketing Status | TE code | RLD | RS |
MESH:D006562 | famvir | famciclovir | 250MG | TABLET;ORAL | Discontinued | None | Yes | No |
MESH:D006562 | famvir | famciclovir | 250MG | TABLET;ORAL | Discontinued | None | Yes | No |
FDA labeling changes(Total Drugs:2) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DiseaseID | Pediatric_Labeling_Date | Trade_Name | Generic_Name_or_Proper_Name | Indications Studied | Label Changes Summary | Product Labeling | BPCA(B) | PREA(P) | BPCA(B) and PREA(P) | Pediatric Rule (R) | Sponsor | Pediatric Exclusivity Granted Date | NNPS |
MESH:D006562 | 12/24/2009 | famvir | famciclovir | Treatment of children 1 month 12 years of age w/ herpes simplex (HSV) & 1 12 years w/ varicella zoster (VSV) | Available data are insufficient to support the use of famciclovir for the treatment of children with chickenpox or infections due to HSV The PK profile and safety were studied in 2 open-label studies: (1) a single-dose PK and safety study in infants 1 month to | Labeling | - | - | B, P | - | Novartis | 09/21/2009 | FALSE' |
MESH:D006562 | 9/2/2012 | famvir | famciclovir | Recurrent herpes labialis | Efficacy has not been established in pediatric patients for the treatment of recurrent herpes labialis Information on an open label PK, safety and efficacy study in children 12 to | Labeling | - | P | - | - | Novartis | - | - |